“European Endocrinology and Diabetes Congress” which is going to be held during April 18-19, 2023 in Madrid, Spain. This conference proposes an unparalleled chance to network with colleagues and learns from distinguished leaders in Endocrinology and Diabetes.

This conference is an extraordinary and leading event ardent to the science with the practice of endocrinology research, which makes a perfect platform for global networking as it brings together renowned speakers, professors, scientists, educationalists, researchers, and students across the globe to a most exciting and memorable scientific meeting to announce and witness the latest scientific and technological breakthroughs in Endocrinology and Diabetes.

ENDOCRINOLOGY 2023 can be targeted in the brand-new & exciting innovations in all areas of Diabetes research offering a specific opportunity for investigators across the globe to meet, network, and perceive new scientific innovations. The topics to be discussed via way of means of certain keynote conferences conducted via way of means of eminent and renowned speakers who come from the sector of diabetes which include Endocrinology and Metabolism, Hormone Dependent Cancers, Thyroid Disorders, Adrenal Disorders, Pituitary, and Neuroendocrinology, Reproductive Endocrinology, Osteoporosis, Bone Health, Endocrine Tumors and Neoplasia, Cardiovascular Endocrinology, Diabetic Nephropathy, Diabetic Retinopathy, Sepsis, and Clinical Trials. This ENDOCRINOLOGY 2023 requests all academic Researchers, Leading Endocrinologists, surgeons, pediatricians, pharmaceutical Industrial Delegates, talented young scientists, and pupil communities across the globe in which all the aspects of Diabetes, Disorders, & Treatment can be talked about under a single roof.The planning committee has designed a comprehensive program features the best in Endocrinology and Diabetes.

Sessions & Tracks:

• Endocrinology and Metabolism
• Thyroid Disease
• Pituitary and Neuroendocrinology
• Adrenal Disorders
• Reproductive Endocrinology
• Osteoporosis and Bone Health
• Endocrine Tumors and Neoplasia
• Cardiovascular Endocrinology
• Hormone Dependent Cancers
• Pediatric Endocrinology
• Genetics and Gene Regulation
• Steroid Hormones and Receptors
• Obesity and Metabolism
• EDCs (Endocrine Disrupting Chemicals)
• Diabetes Therapeutics and Diagnostics
• Diabetic Retinopathy
• Diabetic Nephropathy
• Diabetes and Sepsis
• Herbal and Natural therapies in Diabetes
• Clinical Trials and Research for Diabetes

Market Analysis:

According to the report, the global endocrinology test market is valued at USD 5.5 in 2022 and is expected to grow at a CAGR of 6.4% from 2022. For diabetes: Key Drivers of the Global Endocrine Tests Market.

ENDOCRINOLOGY 2023  consists of endocrine glands that secrete hormones into the bloodstream directly. Tests are done to monitor levels of endocrine hormones (such as follicle-stimulating hormone (FSH), luteinizing hormone (LH), estradiol, insulin, and others) from biological samples. These tests help detect aberrations in hormone production, i.e., they help detect hyper secretion (excessive secretion) or hypo secretion (under secretion) leading to certain endocrine disorders such as infertility, menopause, and menopause. menstruation, thyroid dysfunction and other diseases. Several disorders, including different types of diabetes and PCOS, have led to an increase in endocrine testing. For example, an article published in Current Diabetes Reports indicates that the prevalence of diabetes and PCOS has increased significantly. Hence, more and more people suffering from endocrine and metabolic disorders is a key factor predicted to drive the growth of endocrinology test market.

A sedentary lifestyle and unhealthy diet lead to an increased incidence of diabetes. For example, according to an article published in the Journal of Diabetes Research and Clinical Practice, the worldwide prevalence of diabetes was 463 million in 2019 and will reach 578 million by 2030. This increases the need for new test methods with rapid results. To meet this demand, large companies are investing in research and development activities to develop and introduce products with new technologies, thereby driving the growth of the market.

Growing geriatric population worldwide to drive global endocrinology test market growth:

The steady growth of the geriatric population globally has a direct impact on the development of endocrine testing solutions and methods, as this population is highly susceptible to a number of health disorders and demand for effective hospital management on a global scale. Old age is one of the potential risks of developing hernias, thyroid disorders, and other hormonal imbalances. As a result, endocrine glands and organs undergo a series of changes that affect hormone levels in an elderly person, therefore, the increase in the global geriatric population is one of the main factors driving the market.